Merck Earnings
NYSE: MRKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 29, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$2.14
Merck earnings summary
Merck is scheduled to report Sep/2026 earnings on Oct 29, 2026 before the market opens, with analysts expecting EPS of $2.14. In its most recent report on Aug 7, 2026 (Q2 2026), MRK posted EPS of $-0.54. Revenue for the quarter was $16.61 billion.
Quarterly EPS is down 130.7% from the same quarter a year earlier. Across the last 16 reports, MRK shares moved an average of 3.5% (in either direction) in the first trading session after results, rising 6 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
MRK earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 7, 2026 | — | $-0.54 | — | +5.6% |
| May 4, 2026 | — | $-1.72 | — | 0.0% |
| Feb 24, 2026 | — | $1.19 | — | -6.5% |
| Nov 5, 2025 | — | $2.32 | — | +7.7% |
| Aug 5, 2025 | — | $1.76 | — | +4.4% |
| May 2, 2025 | — | $2.01 | — | -8.7% |
| Feb 25, 2025 | — | $1.49 | — | +2.6% |
| Nov 6, 2024 | — | $1.24 | — | -6.4% |
| Aug 5, 2024 | — | $2.14 | — | -0.8% |
| May 3, 2024 | — | $1.87 | — | +2.0% |
| Feb 26, 2024 | — | $-0.48 | — | -2.7% |
| Nov 3, 2023 | — | $1.86 | — | -1.9% |
| Aug 7, 2023 | — | $-2.35 | — | +1.6% |
| May 5, 2023 | — | $1.11 | — | -0.5% |
| Feb 24, 2023 | — | $1.18 | — | -2.7% |
| Nov 3, 2022 | — | $1.28 | — | -1.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.